NOWDiagnostics develops rapid diagnostic tests that require only a single drop of blood or saliva, providing results in as little as 10 to 15 minutes. Their technology enables at-home testing for conditions like COVID-19 and syphilis, facilitating immediate health assessments without the need for laboratory visits.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional laboratory-based diagnostic testing often requires specialized equipment and trained personnel, leading to delays in obtaining results and limiting accessibility, particularly in point-of-care or at-home settings. This can hinder timely diagnosis and treatment for various health conditions.
Solution
NOWDiagnostics develops and manufactures rapid diagnostic tests that utilize a single drop of blood or saliva to provide results in 10-15 minutes. These tests are designed for point-of-care or over-the-counter use, enabling immediate health assessments without the need for laboratory visits. The tests can be visually interpreted or digitally read using a dedicated analyzer, providing flexibility in result interpretation. The company's technology aims to decentralize diagnostic testing, making it more accessible and convenient for both healthcare professionals and individuals.
Target Audience
The primary target audience includes healthcare professionals such as pharmacists and clinicians, as well as individuals seeking convenient at-home testing options.
Features
- Rapid results in 10-15 minutes using a single drop of blood or saliva
- Fingerstick and saliva-based test formats available
- Tests can be visually interpreted or digitally read using a dedicated analyzer
- Tests available for conditions such as COVID-19 and syphilis
- Intended for point-of-care or over-the-counter use
- Collection devices available for sample preparation